BD Launches New Point-of-Care System for HIV/AIDS Patients

-- Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings SAN JOSE, Calif., May 6, 2014 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD...

2014-05-06 09:00 1186